Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

被引：0
|
作者：
M Ahmed
F Lalloo
A Howell
DG Evans
机构：
[1] Manchester Academic Health Science Centre,
来源：
Breast Cancer Research | / 12卷
关键词：
Breast Cancer; Tamoxifen; Breast Tumour; Cancer Diagnosis; Mutation Carrier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
    KA Phillips
    RL Milne
    MA Rookus
    D Goldgar
    M Friedlander
    SA McLachlan
    S Buys
    AC Antoniou
    K Birch
    MB Terry
    DF Easton
    P Weideman
    M Daly
    N Andrieu
    EM John
    MJ Hooning
    IL Andrulis
    T Caldes
    H Olsson
    JL Hopper
    [J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [32] Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: impact of adjuvant systemic treatment
    Hooning, M.
    Jager, A.
    Koppert, L.
    Van Deurzen, C.
    Collee, M.
    Hollestelle, A.
    Seynaeve, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S140 - S140
  • [33] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    van Sprundel, TC
    Schmidt, MK
    Rookus, MA
    Brohet, R
    van Asperen, CJ
    Rutgers, EJT
    van't Veer, L
    Tollenaar, RAEM
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (03) : 287 - 292
  • [34] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    T C van Sprundel
    M K Schmidt
    M A Rookus
    R Brohet
    C J van Asperen
    E J Th Rutgers
    L J van‘t Veer
    R A E M Tollenaar
    [J]. British Journal of Cancer, 2005, 93 : 287 - 292
  • [35] Parity and breast cancer in BRCA1/BRCA2 carriers
    Narod, S
    [J]. LANCET, 2000, 356 (9230): : 679 - 679
  • [36] Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
    Ikejima, Kengo
    Tokioka, Sayuri
    Yagishita, Kazuyo
    Kajiura, Yuka
    Kanomata, Naoki
    Yamauchi, Hideko
    Kurihara, Yasuyuki
    Tsunoda, Hiroko
    [J]. JOURNAL OF MEDICAL ULTRASONICS, 2023, 50 (02) : 213 - 220
  • [37] Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Krammer, Julia
    Pinker-Domenig, Katja
    Robson, Mark E.
    Gonen, Mithat
    Bernard-Davila, Blanca
    Morris, Elizabeth A.
    Mangino, Debra A.
    Jochelson, Maxine S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 565 - 571
  • [38] Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Kotsopoulos, Joanne
    Huzarski, Tomasz
    Gronwald, Jacek
    Singer, Christian F.
    Moller, Pal
    Lynch, Henry T.
    Armel, Susan
    Karlan, Beth
    Foulkes, William D.
    Neuhausen, Susan L.
    Senter, Leigha
    Tung, Nadine
    Weitzel, Jeffrey N.
    Eisen, Andrea
    Metcalfe, Kelly
    Eng, Charis
    Pal, Tuya
    Evans, Gareth
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01)
  • [39] SECOND BREAST CANCER RISK IN BRCA1 AND BRCA2 MUTATION CARRIERS PATIENTS
    Palazzo, A.
    Iacovelli, R.
    Trenta, P.
    Sidoni, T.
    Ricevuto, E.
    Naso, G.
    Giannini, G.
    Gulino, A.
    Cortesi, E.
    De Marchis, L.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 33 - 33
  • [40] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    Mainor, C. B.
    Isaacs, C.
    [J]. CURRENT BREAST CANCER REPORTS, 2020, 12 (02) : 66 - 74
12345